Home About Login Current Archives Announcements Editorial Board
Submit Now For Authors Call for Submissions Statistics Contact
Home > Archives > Volume 20, No 8 (2022) > Article

DOI: 10.14704/nq.2022.20.8.NQ44739

An Overview about Treatment Modalities of Vitiligo

Khaled Mohamed Gharib, Yasmeen Ahmed Fahmi El Sharkawi, Nagia Ahmed Elmegrab, Al Shimaa Mohamed Ibrahim


Background: Vitiligo is the most common depigmentation disorder where the selective destruction of functioning melanocytes causes depigmentation of the skin, hair and mucosal surfaces. It affects approximately 0.5% to 1% of the population, with an average age of onset at about 24 years, its prevalence appears to be equal between men and women and there is no difference in the rate of occurrence according to skin type or race. The term leucoderma is applied to depigmented patches of known etiology as that following burns, contact with chemicals like phenol or following an inflammatory skin disease. As opposed to vitiligo, it doesn’t progress after the cause is removed. Skin repigmentation is the main goal of therapy regardless of its types; however, spontaneous repigmentation is occurring in about 1%–25% of patients.


Treatment Modalities, vitiligo

Full Text